IGM Biosciences, Inc. (IGMS)
Au 14, 2025 - IGMS was delisted (reason: acquired by Concentra Biosciences)
1.270
-0.030 (-2.31%)
Inactive · Last trade price on Aug 13, 2025
IGM Biosciences Employees
IGM Biosciences had 149 employees as of December 31, 2024. The number of employees decreased by 75 or -33.48% compared to the previous year.
Employees
149
Change (1Y)
-75
Growth (1Y)
-33.48%
Revenue / Employee
$9,065,625
Profits / Employee
-$3,336,563
Market Cap
n/a
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 149 | -75 | -33.48% |
| Dec 31, 2023 | 224 | -34 | -13.18% |
| Dec 31, 2022 | 258 | 66 | 34.38% |
| Dec 31, 2021 | 192 | 85 | 79.44% |
| Dec 31, 2020 | 107 | 43 | 67.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
IGMS News
- 2 months ago - IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right - GlobeNewsWire
- 8 months ago - IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out - Market Watch
- 8 months ago - IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs - GlobeNewsWire
- 10 months ago - IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 months ago - IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewsWire
- 1 year ago - IGM Biosciences' stock tumbles as analysts weigh in on pivot plan with dismay - Market Watch
- 1 year ago - IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO - Benzinga
- 1 year ago - IGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune Diseases - Barrons